ArticleMicrobial pathogenesis2022

Repurposing of anti-lung cancer drugs as multi-target inhibitors of SARS-CoV-2 proteins: An insight from molecular docking and MD-simulation study.

Rahimasoom Reza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.